IPO track­er: Af­ter an­oth­er three pric­ings bring to­tal raise close to $3B, de­buts ex­pect­ed to slow in short week

The End­points News team is con­tin­u­ing to track IPO fil­ings for 2021, and we’re off to an­oth­er hot start af­ter 2020’s record year.

There have al­ready been 16 biotechs to de­but on the Nas­daq so far this year, with Sana lead­ing the way. Its mas­sive IPO raise, which was up­dat­ed to more than $675 mil­lion af­ter the un­der­writ­ers ex­er­cised all their op­tions, makes up the li­on’s share of a com­bined $2.86 bil­lion fundraise.

Endpoints News

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.